Why is Oxygenta Pharma falling/rising?

As of 28-Oct, Oxygenta Pharmaceutical Ltd is experiencing a price increase, currently at Rs 63.88, reflecting a rise of 1.5 (2.4%). The stock has shown a positive trend recently, gaining 9.57% over the last three days and outperforming its sector by 2.66% today. It opened with a significant gain of 4.04% and reached an intraday high of Rs 64.9. However, despite these gains, the stock's performance over the past month has been negative, with a decline of 8.74%, and it has seen a substantial year-to-date drop of 26.97%. Additionally, there has been a decrease in investor participation, with delivery volume falling by 31.78% compared to the five-day average, indicating a potential concern regarding sustained interest in the stock.
Broader market context shows that while Oxygenta has outperformed the Sensex by 4.11% over the past week, it has underperformed significantly over longer periods, with a year-to-date return of -26.97% compared to the Sensex's 8.30% gain. This contrast highlights the stock's volatility and challenges in maintaining investor confidence despite recent short-term gains. The stock's moving averages indicate it is performing better than the five-day average but worse than the longer-term averages, suggesting mixed signals about its future trajectory in the context of broader market performance.